Sensex Today


In a major development with regard to the coronavirus pandemic, the U.S govt. has made a unilateral and highly dominant move🤨.

It has bought nearly the entire world’s supply😳 of remdesivir, one of only two drugs which are known to treat Covid-19.

It is exclusively manufactured🏭 by pharmaceutical giant Gilead.

More about Remdesivir

Remdesivir is an anti-viral medicine💊 that has been used in treating Ebola.

It attacks an enzyme that a virus🦠 needs in order to replicate inside human cells.

Remdesivir has been found to reduce recovery time from 15 to 11 days for those Covid patients😷, which have the most severe infections.

However, this effect has ☝️not been observed in patients with moderate symptoms.

Why U.S took all of it?

At present, the US is easily the topmost Covid impacted country😩 in the world.

Currently, it has over 2.6 million confirmed cases and has recorded more than 1.27 lakh COVID-related deaths😢.

In view of this, the Trump administration has bought more than 500,000 doses of remdesivir, which is equivalent to Gilead’s total production for July and 90% for the months of August and September🗓️.

Significantly, this move has left Gilead with no stocks until October🤷‍♂️ for the rest of the world including other developed countries.

Comes at a price

A typical five-day treatment course👩🏻‍🔬 with Remdesivir will come at around $3,100 (Rs. 2.3 lakhs) per patient in the developed nations.

Meanwhile, Gilead has made an agreement🤝 with 5 generic pharma companies of India and Pakistan under which the drug would be produced and supplied at around $600👍 to 127 poor or middle-income countries.

By admin

One thought on “‘Deal Maker’ Trump strikes again, buys entire stock of Covid-19 drug Remdesivir for the US.”

Leave a Reply

Your email address will not be published. Required fields are marked *